APOE4 testing for Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 45, Issue 9, 1997, Pages 1153-1154

  Karlawish, Jason H T ^a   Sachs, Greg A ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; GENETIC SCREENING; GENETICS; GENOTYPE; HUMAN; METHODOLOGY; NOTE; PREDICTION AND FORECASTING;

ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COST-BENEFIT ANALYSIS; GENETIC SCREENING; GENOTYPE; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 0031227537     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb05986.x     Document Type: Letter

References (6)

1. Roses AD,. Apolipoprotein E genotype. Utility in clinical practice in Alzheimer's disease. J Am Geriatr Soc 1996; 44: 1479-1481.
2. Roses AD,. The predictive value of APOE genotyping in the early diagnosis of dementia of the Alzheimer type: Data from three independent series. Proceedings of the Fifth International Conference on Alzheimer's Disease and Related Disorders, Osaka, Japan, 1996, in press.
3. Kakulas BA, van Bockxmeer F.,. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease. A cautionary view. Ann Neurol 1996; 38: 966-967.
4. Saunders AM, Hulette C., Welsh KA, et al,. Specificity, sensitivity and predictive value of apolipoprotein E genotyping in a consecutive autopsy series of sporadic Alzheimer disease. Lancet 1996; 348: 90-93.
5. Sackett DL, Haynes Brian R., Guyatt GH, Tugwell P.,. The selection of a diagnostic test. In: Clinical Epidemiology. A Basic Science for Clinical Epidemiology. Boston: Little, Brown, and Company, 1991; 51-68.
6. Siu AL,. Screening for dementia and investigating its causes. Ann Intern Med 1991; 115: 122-132.